Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jul 31, 2009

Bruker Sets Up Mass Spectrometry Joint Venture in India

  • Bruker Daltonics and LabMate Asia are establishing a mass spectrometry joint venture called Bruker LabMate. Customer support and technical expertise hubs will be located in Bangalore, Chennai, Delhi, Kolkata, and Mumbai.

    “We already set the customer care standards in India by which other research mass spectrometry suppliers are judged, and we see it as directly responsible for our success,” comments Ian Sanders, Ph.D., evp of Bruker Daltonics. “Adding to our training and applications strength in India is the logical next move to ensure our customers succeed as quickly as possible in this very exciting and dynamic scientific community.”

    The JV is founded on a seven-year partnership between Bruker and LabMate Asia, which served as Bruker’s Indian mass-spectrometry distributor.


Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »